It is strange that a company with, apparently, such a good product like Cardiocel is unable to make money with so many centres already using it.
Even more strange that at such a low... low... share price no other company is even trying to buy the AHZ .... if only to have Cardiocel and ditch the rest of it ..
Like many Bio stocks I think, and this is MHO, that management appear to be happy with their salaries and just keep pushing the company so it can be milked for as long as possible. It appears to be a second job for most anyway.
Think guys, if no one is interested in buying the technology already tested and on the market, it may be because it is not all that good ... and remember there is competition out there ..
Hope is a great crutch, but reality is a different thing all together and only people that aren't emotionally involved can actually see it.
Detach and See!
It is strange that a company with, apparently, such a good...
-
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$15.65 |
Change
-0.060(0.38%) |
Mkt cap ! $300.8M | |||
| Open | High | Low | Value | Volume |
| $15.72 | $15.85 | $15.51 | $1.660M | 117.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 312 | $15.51 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $15.65 | 626 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |